Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2025-12-25 @ 8:40 PM
NCT ID:
NCT05579769
Population Description:
Participants meeting eligibility criteria and who completed study therapy: Allogeneic Human Leukocyte antigen (HLA)-matched sibling or unrelated donor hematopoietic cell transplant (MSD/MUD HCT) for hematological malignancies. Hematological malignancies of the lymphoid lineage will use a standard preparative regimen consisting of Total Body Irradiation and cyclophosphamide (TBI/Cy), unless TBI is contraindicated. Myeloid malignancies will use thiotepa, busulfan, and fludarabine (TBF) regimen.
Study:
NCT05579769
Study Brief:
Results Section:
NCT05579769